Is Kinesio Taping Application Effective on Decreasing Injury Risk for Tennis Players

February 2, 2021 updated by: GUL BALTACI, Guven Health Group

What Kind of Kinesio Taping Material Should be Used to Decrease the Injury Risk Better

Research design: The study protocol was approved and required permissions were taken from related tennis club officials, and a written consent was obtained from all the participants' parents about the study. Thirty-three young tennis players aged between 9 and 12 were included in our study. Assessment were done bare (no tape), after 45 min of performance plus kinesio taping application (PP application) and after 45 min of gold text FP kinesio taping application (GT application). We were randomly taped with either PP or GT taping applications using an online random allocation software program (GraphPad Software QuickCalcs, GraphPad Software Inc., La Jolla, CA, USA). Thirty min of rest was given between 2 taping applications after the removal of the first tape. One participant was not able to complete the second taping procedure. PP and GT taping applications were done by using kinesio taping muscle facilitation techniques to Quadriceps and Gastrosoleus muscles. I-shaped tape with a tension of 10-35% was used for muscle facilitation. All patients were assessed by an experienced physiotherapist, and the tapings were done by another experienced physiotherapist in order to provide a single blind structure of the study.

Study Overview

Detailed Description

Participants: Thirty-three young tennis players aged between 9 and 12 yrs were recruited in the study. The exclusion criteria included those (a) with soft tissue or bone problems affecting lower extremity, (b) who had acute inflammation affecting lower extremity region, (c) had scoliosis, (d) who had undergone any orthopedic surgery, (e) who had defined any pain or painful area at lower extremities and (f) who were obese (BMI>30 kg/m2).

Assessments: Thermal analysis was done for risk of injury including both lower extremities. Quadriceps muscle was chosen from upper leg and gastro soleus muscle was chosen from lower leg region for thermal analysis. The thermo graphic assessment was performed by using FLIR E5 (FLIR Systems AB, Sweden) thermal camera in order to evaluate which muscles had the highest thermal activity while maintaining stable upright posture. The part of muscle with more activation (greater heat) was measured by the thermo graphic camera and the heat was recorded in centigrade. Each participant was thermo graphically evaluated in the same room (ambient temperature, 21°C) and participants were left for 10-20 minutes to 'acclimatize' to the thermographic imaging environment FLIR E5 Thermal Camera, with a resolution of 120 x 90 pixels was used for thermal imaging and the Color Palette iron was chosen for displaying the images. It is indicated that IR imaging may be a reliable and valid measure of treatment outcomes with clinical utility and sensitivity

The power analysis indicated that 33 participants for total were needed with 80 % power and a 5 % type 1 error. The power analysis of our study showed a power of 80% with tissue temperature as the primary outcome. The data were analyzed using statistical software (SPSS version 18, Inc., Chicago, IL, USA). All the statistical analyses were set a priori at an alpha level of p<0.05. The tests for homogeneity (Levene's test) and normality (Shapiro-Wilk) were used to determine the appropriate statistical methods. According to the test results, nonparametric Friedman test was used for comparisons between baseline, first taping and last taping. Wilcoxon test was used for possible differences which may occur between taping applications in order to identify the application that provided the difference. Parametric test assumptions were not possible due to small sample size and inhomogeneous parameters.

Study Type

Interventional

Enrollment (Actual)

32

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Ankara, Turkey, 06500
        • Guven Health Group

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

9 years to 12 years (CHILD)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • at least playing tennis 2 years
  • to be between 9 and 12 years
  • no any sport activity-only tennis
  • to be a volunteer

Exclusion Criteria:

  1. with soft tissue or bone problems affecting lower extremity,
  2. who had acute inflammation affecting lower extremity region,
  3. had scoliosis,
  4. who had undergone any orthopedic surgery,
  5. who had defined any pain or painful area at lower extremities and
  6. who were obese (BMI>30 kg/m2).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: PREVENTION
  • Allocation: NON_RANDOMIZED
  • Interventional Model: CROSSOVER
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: PERFORMANCE PLUS
performance plus better than GOLD TEX
PP and GT taping applications were done by using kinesio taping muscle facilitation techniques to Quadriceps and Gastrosoleus muscles. I tape with a tension of 10-35% was used for muscle facilitation. All patients were assessed by an experienced physiotherapist, and the tapings were done by another experienced physiotherapist in order to provide a single blind structure of the study.
ACTIVE_COMPARATOR: GOLD TEX
GOLD TEX better than performance plus
PP and GT taping applications were done by using kinesio taping muscle facilitation techniques to Quadriceps and Gastrosoleus muscles. I tape with a tension of 10-35% was used for muscle facilitation. All patients were assessed by an experienced physiotherapist, and the tapings were done by another experienced physiotherapist in order to provide a single blind structure of the study.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
termal analysis
Time Frame: 2 hours
Quadriceps muscle was chosen from upper leg and gastro soleus muscle was chosen from lower leg region for thermal analysis. The thermo graphic assessment was performed by using FLIR E5 (FLIR Systems AB, Sweden) thermal camera in order to evaluate which muscles had the highest thermal activity while maintaining stable upright posture. The part of muscle with more activation (greater heat) was measured by the thermo graphic camera and the heat was recorded in centigrade. Each participant was thermo graphically evaluated in the same room (ambient temperature, 21°C) and participants were left for 10-20 minutes to 'acclimatize' to the thermographic imaging environment FLIR E5 Thermal Camera, with a resolution of 120 x 90 pixels was used for thermal imaging.
2 hours
vertical jump
Time Frame: 1 hours
A vertical jump test was performed before and after the application of Kinesio taping® to their quadriceps and gastrocnemius muscles according to Kase's recommendations. The height and flight time data was collected using a portable optical timing system (Optojump Next; Microgate, Bolzano, Italy) during a counter movement jump. Mean maximum jump height and flight time were averaged from three attempts. Two-way repeated measures ANOVAs were used to assess the influence taping condition on vertical jump performance.
1 hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
age
Time Frame: through study completion, an average of 8 weeks
Sports age is important to determine the description of differences between ages and sexes.
through study completion, an average of 8 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: YESIM S CETINKAYA, MD, Guven Health Group

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

September 24, 2020

Primary Completion (ACTUAL)

December 25, 2020

Study Completion (ACTUAL)

January 30, 2021

Study Registration Dates

First Submitted

July 24, 2019

First Submitted That Met QC Criteria

August 15, 2019

First Posted (ACTUAL)

August 16, 2019

Study Record Updates

Last Update Posted (ACTUAL)

February 4, 2021

Last Update Submitted That Met QC Criteria

February 2, 2021

Last Verified

February 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 511 (Istanbul Science University)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

Each participant was thermo graphically evaluated in the same room (ambient temperature, 21°C) and participants were left for 10-20 minutes to 'acclimatize' to the thermographic imaging environment FLIR E5 Thermal Camera, with a resolution of 120 x 90 pixels was used for thermal imaging and the Color Palette iron was chosen for displaying the images. It is indicated that IR imaging may be a reliable and valid measure of treatment outcomes with clinical utility and sensitivity

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Injury

Clinical Trials on Kinesio Taping (Performance Plus)

3
Subscribe